Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arts Way Manufacturing (ARTW) Other Accumulated Expenses (2016 - 2026)

Arts Way Manufacturing's Other Accumulated Expenses history spans 16 years, with the latest figure at $167108.0 for Q1 2026.

  • Quarterly results put Other Accumulated Expenses at $167108.0 for Q1 2026, down 28.74% from a year ago — trailing twelve months through Feb 2026 was $167108.0 (down 28.74% YoY), and the annual figure for FY2025 was $373140.0, up 35.75%.
  • Other Accumulated Expenses for Q1 2026 was $167108.0 at Arts Way Manufacturing, down from $373140.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $373140.0 in Q4 2025 to a low of $167108.0 in Q1 2026.
  • The 5-year median for Other Accumulated Expenses is $287442.0 (2024), against an average of $285382.6.
  • Peak annual rise in Other Accumulated Expenses hit 35.75% in 2025, while the deepest fall reached 29.08% in 2025.
  • Year by year, Other Accumulated Expenses stood at $294778.0 in 2022, then rose by 1.16% to $298211.0 in 2023, then fell by 7.83% to $274870.0 in 2024, then skyrocketed by 35.75% to $373140.0 in 2025, then tumbled by 55.22% to $167108.0 in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $167108.0, $373140.0, and $247033.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.